1. Home
  2. ASMB vs SHMD Comparison

ASMB vs SHMD Comparison

Compare ASMB & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$27.09

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

HOLD

Current Price

$5.38

Market Cap

279.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
SHMD
Founded
2005
1864
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
279.8M
IPO Year
2010
2023

Fundamental Metrics

Financial Performance
Metric
ASMB
SHMD
Price
$27.09
$5.38
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$44.20
N/A
AVG Volume (30 Days)
130.1K
417.1K
Earning Date
05-06-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$638.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.23
$2.00
52 Week High
$39.71
$10.65

Technical Indicators

Market Signals
Indicator
ASMB
SHMD
Relative Strength Index (RSI) 55.77 59.71
Support Level $26.29 $4.78
Resistance Level $30.36 $5.47
Average True Range (ATR) 1.03 0.36
MACD 0.16 0.18
Stochastic Oscillator 90.81 89.56

Price Performance

Historical Comparison
ASMB
SHMD

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: